Job Opportunities API

The Public Ledger of Openings

← Back to the ledger

Clinical Research Lead (Biology Informed Drug Development)

The Michael J. Fox Foundation for Parkinson's Research
CompanyThe Michael J. Fox Foundation for Parkinson's Research
CategoryHealthcare
LocationUnited States
RemoteOn-site (inferred)
EmploymentNot stated
LevelLead
SalaryNot stated by the employer
Posted23 Jun 2026
Last verified12 Aug 2026
SourceEmployer ATS (greenhouse)
Applications are handled by the employer, not by us.Apply on the employer's site →
Description
Job Title:  Clinical Research Lead (Biology Informed Drug Development)   Position Summary:    The Michael J. Fox Foundation for Parkinson’s Research (“the Foundation”) is seeking top talent for its Clinical Research Lead (Biology Informed Drug Development) position.  You will play a critical role in shaping and executing strategic programs that accelerate the development of Parkinson’s disease treatments.  This role will provide scientific leadership across clinical-stage pharmacologic programs and biologically informed initiatives, while serving as a critical bridge between Translational Research and Clinical Development.   Success requires strong curiosity, collaboration, and the ability to connect scientific, clinical, and market insights to advance innovative therapies.   This position may be hybrid-flex with the opportunity to work from the Foundation’s office in NYC or based remotely from anywhere within the U.S.   Primary Duties & Responsibilities:    Strategic Leadership: Lead and execute strategic programs that align with the Foundation’s patient-centered priorities and therapeutic research vision, ensuring a de-risked and patient-centric clinical development approach   Program and Portfolio Management: Manage research and clinical program portfolios at all stages—from concept development, review, and grant contracting to milestone management and troubleshooting during execution. Evaluate and establish mechanisms for sourcing and supporting clinical-stage therapeutic programs, including grants and strategic partnerships   Clinical Development & Strategy: Develop new initiatives to clarify clinical, regulatory, and commercial development paths for novel Parkinson’s treatments. Proactively monitor emerging trends to position the Foundation for maximum impact in the Parkinson’s clinical landscape   Patient Integration: Ensure the voice of the patient is integrated into all the Foundation’s therapeutic strategies. Leverage patient experience data to inform clinical development and decision-making   Resource Allocation & Prioritization: Manage resource allocation and prioritization to meet clinical development goals with urgency. Ensure efficient use of resources across internal and external teams to achieve high-impact results   Executive Communication & Reporting: Develop and deliver executive-level communications to highlight the impact of the Foundation’s therapeutic funding programs. Track and report program progress, milestones, and risks to ensure strategic alignment and cross-functional coordination   Stakeholder Relationship Management: Build and maintain strong relationships with key external stakeholders, including biopharma companies, KOLs, regulatory bodies, and patient advocacy organizations, to drive strategic collaborations   Collaboration & Cross-functional Leadership: Serve as a thought leader and accountability partner to cross-functional initiatives, driving alignment and ensuring progress against department and business unit Key Performance Indicators (KPIs)   Strategic Planning Support: Contribute to annual strategic planning for the Clinical Research department, including resourcing, prioritization, and assessing performance against scientific and funding goals     Qualifications and Skills:    Advanced scientific (PhD, MD) or business degree (e.g., MBA) is strongly preferred   Proven experience in clinical research, biopharma or healthcare consulting, including managing cross-functional teams, developing therapeutic programs, and driving strategic initiatives in biopharma, academia, or non-profit sectors